Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
US7723326B2 · kind B2 · utility
7Cited by
3References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2006 |
| Grant date | May 25, 2010 |
| Priority date | — |
| Expiry date | Jul 8, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D265/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula (I),methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating RXR mediated disorders. More particularly, the compounds of the present invention are RXR agonists useful for treating RXR mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.